Evaluating the neonatal BCG vaccination programme in Ireland

نویسندگان

  • Cara Usher
  • Roisin Adams
  • Susanne Schmitz
  • Jennifer Kieran
  • Darina O’Flanagan
  • Joan O’Donnell
  • Kevin Connolly
  • Brenda Corcoran
  • Karina Butler
  • Michael Barry
  • Cathal Walsh
چکیده

BACKGROUND The aim of this study was to compare the cost effectiveness of the current Irish programme of universal BCG vaccination of infants versus a programme which considered selectively vaccinating high risk infants using decision analytical modelling. METHODS The efficacy of the BCG vaccine was re-evaluated to inform a decision analytical model constructed to follow a birth cohort of vaccinated and unvaccinated infants over a 15 year time horizon. The number of life years gained (LYG) was the primary outcome measure and this was compared to the net cost of the vaccination strategies. RESULTS In the base case analysis, the incremental cost effectiveness ratios (ICERs) for the universal strategy and selective strategy vs no vaccination were €204,373/LYG and €143,233/LYG respectively. When comparing the incremental difference in moving from the universal to the selective strategy, the selective strategy costs €1,055,692 less per 4.8 life years lost per birth cohort. One way sensitivity analyses highlighted that a move from the universal to the selective strategy was particularly sensitive to the estimate of vaccine efficacy against deaths, the cost of administering the vaccine and the multiplier used to apportion risk of contracting tuberculosis. Probabilistic analysis suggested that a move from a universal based strategy to a selective based strategy could be deemed cost effective (probability of cost effectiveness is 76.8 %). CONCLUSION The results of the study support the protective effect of the BCG vaccine in infants and quantified the cost effectiveness of the current BCG vaccination strategy and the decremental difference in moving to a selective strategy. This analysis highlights that the additional protection offered by the universal vaccination strategy is small compared to that of the selective strategy. Consideration should therefore be given to the implementation of a selective vaccination strategy, and diverting resources to improve TB case management and control.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis.

Data from the 1986 and 1991 National Tuberculosis Survey were used, together with the Census of Population for those years, to try and determine whether bacille Calmette-Guerin (BCG) vaccination policy had any influence on the reported incidence of tuberculosis in the Republic of Ireland. The age-specific incidence of tuberculosis for the country as a whole and for local areas, was determined w...

متن کامل

Ethnic differences in the rates of BCG vaccination.

An audit of the selective neonatal BCG immunisation programme showed that only 51% of eligible infants received the vaccination. Infants of Indian subcontinental origin (ISC) were significantly more likely to have been vaccinated than non-ISC infants (ISC 70% v non-ISC 29%). Greater awareness of the eligibility of non-ISC infants for BCG as well as simplification of the eligibility criteria are...

متن کامل

An evaluation of the results of mantoux test in children received BCG vaccine during the neonatal period

BCG vaccination has an important role in preventing the serious forms of tuberculosis in children.adverse effects of BCG vaccination are uncommon in immunocompetent children.one of the side effects of BCG vaccine is its potential for produsing hypersensitivity to tuberculin and difficulties in interpretation of PPD test results.Knowledge of the normal variations in the induration of Mantoux(PPD...

متن کامل

ارزیابی میزان تأثیر واکسیناسیون B.C.G در دوره نوزادی

BCG vaccine has been used since 1921 for primary prevention of tuberculosis in man. The immunogenic efficacy of this vaccine has been reported between 2 to 83/. in various studies. In order to assess the efficacy of neonatal BCG vaccination in 200 infants who had received BCG vecctne at birth, BCG vaccine scars were measured and PPD test (5 unit strength) was performed at 3 months of age. The s...

متن کامل

Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.

BACKGROUND Neonatal BCG vaccination is part of routine vaccination schedules in many developing countries; vaccination at school age has not been assessed in trials in low-income and middle-income countries. Catch-up BCG vaccination of school-age children who missed neonatal BCG vaccination could be indicated if it confers protection and is cost-effective. We did a cluster-randomised trial (BCG...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 74  شماره 

صفحات  -

تاریخ انتشار 2016